Aims and scope
International Journal of Retina and Vitreous focuses on the ophthalmic subspecialty of vitreoretinal disorders. The journal presents original articles on new approaches to diagnosis, outcomes of clinical trials, innovations in pharmacological therapy and surgical techniques, as well as basic science advances that impact clinical practice. Topical areas include, but are not limited to:
- Imaging of the retina, choroid and vitreous
- Innovations in optical coherence tomography (OCT)
- Small-gauge vitrectomy, retinal detachment, chromovitrectomy
- Electroretinography (ERG), microperimetry, other functional tests
- Intraocular tumors
- Retinal pharmacotherapy & drug delivery
- Diabetic retinopathy & other vascular diseases
- Age-related macular degeneration (AMD) & other macular entities
All articles published by International Journal of Retina and Vitreous are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in International Journal of Retina and Vitreous you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
The publication costs for International Journal of Retina and Vitreous are covered by the Brazilian Retina and Vitreous Society, so authors do not need to pay an article-processing charge for each article accepted for publication.
All articles published in International Journal of Retina and Vitreous are included in:
- PubMed Central
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including Web of Science and Scopus to ensure that articles published in International Journal of Retina and Vitreous will be available in their databases when appropriate.
After an initial screening for general suitability, the Editors will assign submissions for external peer review. The journal will operate a 'closed' peer-review policy, and will aim to reach a first decision within six weeks.
Edited by Jay S Duker and Eduardo B Rodrigues, International Journal of Retina and Vitreous is supported by an expert Editorial Board.
Authors will be able to check the progress of their manuscript at any time by logging into the journal's submission system.
All manuscripts submitted to International Journal of Retina and Vitreous should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Citing articles in International Journal of Retina and Vitreous
Articles in International Journal of Retina and Vitreous should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Int J Retin Vitr [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Int J Retin Vitr 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in International Journal of Retina and Vitreous
International Journal of Retina and Vitreous's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
International Journal of Retina and Vitreous offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in International Journal of Retina and Vitreous gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in International Journal of Retina and Vitreous are included in article alerts and regular email updates. Some may be highlighted on International Journal of Retina and Vitreous’s pages and on the BioMed Central homepage.
In addition, articles published in International Journal of Retina and Vitreous may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in International Journal of Retina and Vitreous. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in International Journal of Retina and Vitreous you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.